3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Leukemia, Biphenotypic, Acute
1
Interventions
Methotrexate
7
Cyclophosphamide
7
Methylprednisolone
6
merphos
5
Cytarabine
5
Asparaginase
5
pegaspargase
4
Vincristine
4
Specimen Handling
4
Mercaptopurine
4
Leucovorin
4
Dexamethasone
4
Daunorubicin
4
dexamethasone acetate
3
dexamethasone 21-phosphate
3
calaspargase pegol
3
azathiopurine
3
auricularum
3
Thioguanine
3
Prednisolone
3
Hydrocortisone
3
Etoposide
3
Doxorubicin
3
Calcium Dobesilate
3
Antilymphocyte Serum
3
prednylidene
2
liposomal amphotericin B
2
exifone
2
deltacortene
2
blinatumomab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Leukemia, Biphenotypic, Acute
×
Nalbuphine
×
Clear all
NCT03825887
2021-08-02
PCA
Children's Cancer Hospital Egypt 57357
Phase 3
Completed
80 enrolled